文献速递睡眠呼吸障碍

持续气道正压通气治疗与睡眠呼吸暂停患者性生活质量的相关性:一项随机临床试验的随访研究

Association of Continuous Positive Airway Pressure Treatment With Sexual Quality of Life in Patients With Sleep Apnea: Follow-up Study of a Randomized Clinical Trial.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2018-01-01

该前瞻性队列研究纳入182例新诊断的重度阻塞性睡眠呼吸暂停患者,随访12个月,使用SNORE-25量表评估性生活质量(0-5分,分数越高越差)。结果显示,CPAP使用者的性生活质量改善优于非使用者(差异0.54,95%CI 0.18-0.90),校正混杂因素后差异仍显著(0.49,95%CI 0.09-0.89);亚组分析显示女性改善显著,男性无显著改善。

要点

  • CPAP使用与性生活质量改善相关,校正后差异0.49(95%CI 0.09-0.89)。
  • 女性亚组显示大幅改善(校正差异1.34,95%CI 0.50-2.18),男性无显著改善。
  • 研究为前瞻性队列,需进一步研究其他性生活质量指标和治疗方法。

核心结论

  • 成功的CPAP使用可能与性生活质量改善相关,女性亚组改善显著,男性无改善。

研究设计与样本

  • 前瞻性队列研究,单中心三级医疗中心,纳入182例新诊断阻塞性睡眠呼吸暂停并处方CPAP的患者,随访12个月。

主要发现

  • CPAP使用者(每晚平均6.4小时)较非使用者(0小时)性生活质量评分改善更大(0.7 vs 0.1;差异0.54;95%CI 0.18-0.90;效应量0.47)。
  • 校正年龄、性别、种族、婚姻状况、收入、教育、BMI、AHI和功能共病指数后,调整差异为0.49(95%CI 0.09-0.89;效应量0.43)。
  • 女性亚组校正差异1.34(95%CI 0.50-2.18;效应量0.87),男性亚组校正差异0.16(95%CI -0.26至0.58;效应量0.19)。

关键数值与推荐

  • CPAP使用者定义为每晚使用超过4小时,非使用者定义为每晚使用少于0.5小时。
  • 性生活质量域评分范围0-5分,分数越高越差。

临床怎么用

  • 对于阻塞性睡眠呼吸暂停患者,尤其是女性,成功CPAP治疗可能改善性生活质量。
  • 男性患者性生活质量改善不显著,需进一步评估其他干预措施。

局限性

  • 研究为单中心前瞻性队列,非随机对照,可能存在残余混杂。
  • 性生活质量仅通过SNORE-25量表的2个条目评估,需进一步验证其他测量工具。
  • 亚组分析样本量有限,女性改善结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Obstructive sleep apnea reduces sexual quality of life (QOL) as a result of reduced libido and intimacy, erectile dysfunction, and several other mechanisms. Treatment for obstructive sleep apnea may improve sexual QOL. OBJECTIVE: To test the association of long-term continuous positive airway pressure (CPAP) treatment with sexual QOL for patients with obstructive sleep apnea. DESIGN, SETTING, AND PARTICIPANTS: Prospective cohort study at a single, tertiary medical center of patients with newly diagnosed obstructive sleep apnea who were prescribed CPAP treatment from September 1, 2007, through June 30, 2010 (follow-up completed June 30, 2011). The statistical analysis was performed from February 1 through December 31, 2017. EXPOSURES: Use of CPAP treatment objectively measured by the number of hours per night. Users of CPAP were defined as patients who used CPAP treatment for more than 4 hours per night, and nonusers were defined as patients who used CPAP treatment for fewer than 0.5 hours per night. MAIN OUTCOMES AND MEASURES: Data were collected from eligible patients before CPAP treatment was prescribed and 12 months later by using the validated Symptoms of Nocturnal Obstruction and Related Events-25 (SNORE-25) QOL instrument. The 2 sex-specific items used to create the sexual QOL domain were taken from the SNORE-25. The sexual QOL domain was scored in a range from 0 to 5 (higher score is worse). The difference in sexual QOL between CPAP users and nonusers was analyzed using a paired, 2-tailed t test and multivariable linear regression adjusted for potential confounders. RESULTS: Of the 182 participants in the cohort, 115 (63.2%) were men (mean [SD] age, 47.2 [12.3] years) with severe OSA (mean [SD] apnea-hypopnea index, 32.5 [23.8] events per hour). At the 12-month follow-up, 72 CPAP users (mean [SD] use, 6.4 [1.2] hours per night) had greater improvement than 110 nonusers (0 [0] hours per night) in sexual QOL scores (0.7 [1.2] vs 0.1 [1.1]; difference, 0.54; 95% CI, 0.18-0.90; effect size, 0.47). A moderate treatment association was observed after adjustment for age, sex, race/ethnicity, marital status, income level, educational level, body mass index, apnea-hypopnea index, and the Functional Comorbidity Index (adjusted difference, 0.49; 95% CI, 0.09-0.89; effect size, 0.43). Subgroup analysis revealed a large treatment association for women (adjusted difference, 1.34; 95% CI, 0.50-2.18; effect size, 0.87) but not for men (adjusted difference, 0.16; 95% CI, -0.26 to 0.58; effect size, 0.19). CONCLUSIONS AND RELEVANCE: Successful CPAP use may be associated with improved sexual QOL. Subgroup analysis revealed a large improvement in women but no improvement in men. Further study is warranted to test other measures of sexual QOL and other treatments. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT00503802.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Jara SM, Hopp ML, Weaver EM, et al. Association of Continuous Positive Airway Pressure Treatment With Sexual Quality of Life in Patients With Sleep Apnea: Follow-up Study of a Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2018. PMID: 29800001. doi:10.1001/jamaoto.2018.0485

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。